Uterine Fibroids

The authors noted that both primary options for treatment are currently being debated as to their efficacy and safety.

Many of the glaring disparities that exist in care for the 26 million women in the United States who suffer from uterine fibroids, which disproportionately affects up to 80% of Black women, are being aggressively addressed though a new multifaceted campaign called UNmuting Fibroids.

Vitamin D and green tea extract resulted in a significant reduction in the mean size of uterine fibroids among women of later reproductive age, according to a recent study.

A retrospective study that investigated the effectiveness and feasibility of fibroid enucleation in the anterior wall of the uterus by transverse uterine incision during cesarean section.

A study has once again validated ultrasound-guided high-intensity focused ultrasound (USgHIFU) as an effective technique to devascularize uterine fibroids.

Due to uterine fibroids being a potential cause of infertility, treatment options like myomectomy should be discussed individually with the patient, according to an article published in Diagnostics that evaluated the relationship.

A systematic review of minimally invasive treatments for uterine fibroid-related bleeding found that myomectomy can improve overall bleeding symptoms in nearly all patients.

A study examined the treatment efficacy of uterine artery embolization (UAE) or magnetic resonance imaging-guided focused ultrasound surgery (MRgFUS) for uterine fibroids.

A Swedish cohort study in the journal Environment International has found that women of fertile age who were exposed to high levels of perfluorinated substances (PFAS) in drinking water were significantly more likely to subsequently have a diagnosis of polycystic ovarian syndrome (PCOS) and possibly uterine leiomyoma (or uterine fibroids [UFs]), but not endometriosis.

One in 10 women with singleton pregnancies have at least 1 uterine fibroid (UF), according to a prospective cohort study.

Several dietary supplements and nutrients potentially provide benefits in preventing and treating common gynecological diseases like uterine fibroids (UFs), endometriosis, polycystic ovarian syndrome (PCOS), infertility, menstrual disorders and vaginal infections, according to an article in the journal Nutrients.

Emergency department (ED) visits in women affected by leiomyomas, or uterine fibroids (UFs), are increasing, but hospital admissions for this patient population are decreasing, according to a study published in the journal Obstetrics & Gynecology.

The American College of Obstetricians and Gynecologists (ACOG) recently published an updated committee opinion regarding morcellation of presumed uterine leiomyoma. Here are the key points.

No evidence exists that bacterial vaginosis (BV)-associated bacteria increases the risk of developing uterine fibroids (UFs) or the number of UFs, according to a nested case-control study in the journal Sexually Transmitted Diseases.

A pending prospective, multi-center study will assess whether mothers with cystic fibrosis can maintain their health if they become pregnant.

A qualitative study in the Journal of Racial and Ethnic Health Disparities has concluded that ethnic and racial considerations can have significant impact on patient experience of uterine fibroid (UF) diagnosis and management.

Fibroid uterus cases with anemia in premenopausal women are more likely to have vitamin D deficiency as compared to cases without anemia, according to a study from India in the journal Cureus.

A prospective study has concluded that women of childbearing age with uterine fibroids (UF) who desire to preserve fertility benefit from the combined oral supplementation of vitamin D, epigallocatechin gallate (EGCG) and vitamin B6.

Senior editor Angie DeRosa interviewed Sateria Venable, Founder & CEO of the Fibroid Foundation, and Ayman Al-Hendy, MD, a professor of ob/gyn at the University of Chicago Medical Center, about patient-physician collaboration when it comes to addressing uterine fibroids.

Transcervical fibroid ablation (TFA) to treat symptomatic uterine fibroids (UFs) is effective for a wide range of fibroid types and sizes, according to preliminary results of the first 160 women treated in the Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE registry).

As there is a higher rate of uterine fibroids among Black women, researchers seek to find the cause.

The COMPARE-UF Experience provides relevant information for patients and their providers in choosing a surgical treatment for uterine fibroid (UF) symptoms.

“New studies are showing significantly increased risks of cardiovascular disease, weight gain and mood disorders, even with bilateral ovarian conservation,” Elizabeth A. Stewart, MD, told Contemporary OB/GYN.

When it comes to diagnosing women with uterine fibroids (UFs), no single patient, fibroid or lived experience is the same, according to Sony Sukhbir Singh, MD, a professor of gynecology at the University of Ottawa and The Ottawa Hospital in Ontario, Canada.

A better understanding of the pathophysiology of uterine fibroids (UFs) will enable healthcare providers to deliver high-quality informed care to their patients, according to Ayman Al-Hendy, MD, PhD, a professor of ob/gyn at Pritzker School of Medicine, University of Chicago.

The two most common symptomatic types of uterine fibroids (UFs) are intramural and subserosal, according to an unpublished study from Jordan.

A study in the Journal of Maternal-Fetal and Neonatal Medicine found that the combination of a cervical procedure and vaginal micronized progesterone helped achieve term deliveries in more than 90% of pregnant women with large uterine fibroids (UFs).

Black women are more likely to undergo uterine fibroid (UF) treatments that are uterine-sparing compared with their White counterparts, according to a prospective cohort study in the Journal of Women’s Health.

A retrospective study in the journal Obstetrics & Gynecology and Reproductive Health has concluded that total laparoscopic retrograde hysterectomy (TLreH) for severe endometriosis with obliterated cul-de-sac is both feasible and safe.

Women with submucosal uterine leiomyomas who undergo hysteroscopic removal have comparable birth outcomes to women with submucosal uterine leiomyomas who do not have hysteroscopic removal, according to a retrospective case-control study in the American Journal of Obstetrics & Gynecology MFM.